FDA ready for consumers on review of silicone implants
This article was originally published in Clinica
Executive Summary
The US FDA is taking unusual precautions in its planning for next week's historic panel meeting on whether silicone-gel breast implants should return to the market, mindful that consumer groups are looking for any opportunity they can use to block the proceedings.